Intriguingly, simultaneous inhibition of B-rapidly accelerated fibrosarcoma (BRAF) (V600E) and PERK in melanoma increases chemosensitivity, suggesting that the balance between autophagy mediated by UPR and chemotherapy is essential for the overcoming of chemoresistance. Here, EIF2AK3 is linked to melanoma.